These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35948779)

  • 1. Research progress in the early diagnosis of Parkinson's disease.
    Xie L; Hu L
    Neurol Sci; 2022 Nov; 43(11):6225-6231. PubMed ID: 35948779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Position Emission Tomography/Single-Photon Emission Tomography Neuroimaging for Detection of Premotor Parkinson's Disease.
    Zou J; Weng RH; Chen ZY; Wei XB; Wang R; Chen D; Xia Y; Wang Q
    CNS Neurosci Ther; 2016 Mar; 22(3):167-77. PubMed ID: 26776081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of neuroimaging in Parkinson's disease.
    Bidesi NSR; Vang Andersen I; Windhorst AD; Shalgunov V; Herth MM
    J Neurochem; 2021 Nov; 159(4):660-689. PubMed ID: 34532856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging the Nonmotor Symptoms in Parkinson's Disease.
    Yousaf T; Wilson H; Politis M
    Int Rev Neurobiol; 2017; 133():179-257. PubMed ID: 28802921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging in Parkinson's Disease.
    Politis M; Pagano G; Niccolini F
    Int Rev Neurobiol; 2017; 132():233-274. PubMed ID: 28554409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease.
    Rolinski M; Griffanti L; Piccini P; Roussakis AA; Szewczyk-Krolikowski K; Menke RA; Quinnell T; Zaiwalla Z; Klein JC; Mackay CE; Hu MT
    Brain; 2016 Aug; 139(Pt 8):2224-34. PubMed ID: 27297241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Saeed U; Lang AE; Masellis M
    Front Neurol; 2020; 11():572976. PubMed ID: 33178113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New molecular targets for PET and SPECT imaging in neurodegenerative diseases.
    Benadiba M; Luurtsema G; Wichert-Ana L; Buchpigel CA; Busatto Filho G
    Braz J Psychiatry; 2012 Oct; 34 Suppl 2():S125-36. PubMed ID: 23429844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview: Radiotracers and nano-radiopharmaceuticals for diagnosis of Parkinson's disease.
    Ozolmez N; Silindir-Gunay M; Volkan-Salanci B
    Appl Radiat Isot; 2024 Jan; 203():111110. PubMed ID: 37989065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotracers for imaging of Parkinson's disease.
    Abbasi Gharibkandi N; Hosseinimehr SJ
    Eur J Med Chem; 2019 Mar; 166():75-89. PubMed ID: 30685535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging advances in Parkinson's disease.
    Rispoli V; Schreglmann SR; Bhatia KP
    Curr Opin Neurol; 2018 Aug; 31(4):415-424. PubMed ID: 29878908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
    Meles SK; Oertel WH; Leenders KL
    Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging the aetiology of sleep disorders in dementia and Parkinson's disease.
    Pavese N
    Curr Neurol Neurosci Rep; 2014 Dec; 14(12):501. PubMed ID: 25341374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the Gut Microbiome in Parkinson's Disease.
    Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
    Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-photon emission computed tomography in diagnosis and differential diagnosis of Parkinson's disease.
    Isaias IU; Antonini A
    Neurodegener Dis; 2010; 7(5):319-29. PubMed ID: 20616566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of neuroimaging in the early diagnosis and evaluation of Parkinson's disease.
    Seibyl J; Jennings D; Tabamo R; Marek K
    Minerva Med; 2005 Oct; 96(5):353-64. PubMed ID: 16227950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Prange S; Hermier M; Danaila T; Laurencin C; Thobois S
    Presse Med; 2017 Mar; 46(2 Pt 1):202-209. PubMed ID: 28040345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease.
    Qamhawi Z; Towey D; Shah B; Pagano G; Seibyl J; Marek K; Borghammer P; Brooks DJ; Pavese N
    Brain; 2015 Oct; 138(Pt 10):2964-73. PubMed ID: 26209314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic use of functional imaging in Parkinson's disease and related disorders].
    Hanakawa T; Kawasaki K; Hashikawa K; Fukuyama H
    Nihon Rinsho; 2004 Sep; 62(9):1733-8. PubMed ID: 15462394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging Markers in Genetic Forms of Parkinson's Disease.
    Droby A; Thaler A; Mirelman A
    Brain Sci; 2023 Aug; 13(8):. PubMed ID: 37626568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.